The tariff classification of bilevel positive airway pressure devices from China or other country
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Key passages, quoted from the ruling
- The applicable subheading for the Hypnus BiPAP devices will be 9019.20.0000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “[o]zone therapy, oxygen therapy, aerosol therapy, artificial respiration or other therapeutic respiration apparatus; parts and accessories thereof.” The general rate of duty will be free.
Ruling text
In your letter dated September 3, 2025 , you requested a tariff classification ruling on behalf of your client, Movair Inc. Additional information was provided by email dated September 26 and September 29, 2025. The products under consideration are four models of Hypnus Bilevel Positive Airway Pressure (BPAP or BiPAP) devices: models BA825, BA825W, ST830, and ST830W.
All models are intended to provide non-invasive, positive airway pressure to spontaneously breathing patients in a professional healthcare facility and/or a home healthcare environment. A doctor’s prescription is required to purchase these devices. Each device consists of a main unit, a humidifier, a heating tube, a mask, and a power supply adapter. The main unit has an interface screen indicating adjustments of ramp-time, temperature, humidity, and user settings.
On the front of the device is the 22mm airway tube connection; the other side of the airway tube connects with the mask. The humidifier is filled with water via a cover on top of the device and attaches to the main unit. Based on the preset settings, the device outputs a certain level of positive airway pressure and air flow through the tubing and nasal mask to provide non-invasive ventilatory support for patients with obstructive sleep apnea or respiratory insufficiency.
The inspiration duration settings of all models are Ti Min: 0.1-4.0 seconds and Ti Max: 0.3-4.0 seconds. The model BA825 and model BA825W operate within a pressure range of 4-25cmH2O and support CPAP mode, BPAP-S, and Auto BPAP-S modes. The model ST830 and model ST830W offer CPAP mode, BPAP-S, BPAP-ST, and BPAP-T modes. Both operate within a higher pressure range of 4-30cmH2O and include a respiratory rate setting of 5-40 bpm in BPAP-ST mode.
The ST830W model adds wireless connectivity for data transfer, which the ST830 lacks. You explain that the construction and design of the Hypnus BiPAP devices shows that they are intended for use only by chronic patients (patients with chronic conditions). The Hypnus BiPAP machines are designed and intended for home use.
BiPAP machines for home use such as the Hypnus models are intended to provide long-term management of chronic respiratory conditions such as Chronic Obstructive Pulmonary Disease (“COPD”) or sleep apnea. They are not designed for use in acute care settings, and so therefore do not have alarms and monitoring systems to continuously monitor the vital signs of the patients and allow immediate intervention to provide additional care if necessary.
Instead, because they are meant for long-term use, they have features such as heated humidifiers meant to increase the comfort of their users, and are more compact and quieter than BiPAP machines meant for acute care settings. By contrast, BiPAP machines for use by patients with acute difficulty breathing (acute patients) are designed for use in an acute care setting.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N353194).